STELFONTA Superstar

Special guest appearance by
Jamie Rauscher, (past NAVTA President) and
Dr. Pamela Jones, Chief STELFONTA^® oncologist.

Course Highlights:

Fun Flexible Learning: 4 x 1-hour video modules available on-demand.
Comprehensive Topics:
- Case Selection: Identifying the best candidates for STELFONTA
- Cytologic grading: Master the nuances
- Latest pain management techniques
- The vital role technicians play in client support
- Tips for successful treatment
- Real clinical case shares... and more!

Why Enroll?

Certification: Gain recognition as a STELFONTA^® Superstar
VIP invitations: Exclusive cocktail events at key conferences
Superstar Status: Your name listed on "Find a veterinarian" services
Part of an ongoing community: Drop in to scheduled zooms with Dr. Ettinger and discuss cases
Expert Guidance: Learn from leading experts in veterinary oncology
Convenience: Study at your own pace, anytime, anywhere

This pathway has been approved for 4.0 hour of continuing education credit in jurisdictions that recognize RACE^® approval.

IMPORTANT SAFETY INFORMATION

Accidental self-injection of STELFONTA^® (tigilanol tiglate injection) may cause severe wound formation. To decrease the risk of accidental self-injection, sedation of the dog may be necessary. In dogs, do not inject STELFONTA into subcutaneous mast cell tumors located above the elbow or hock. Formation of wounds, possibly extensive, is an intended and likely response to treatment with STELFONTA along with associated swelling, bruising and pain; these wounds are expected to heal. Appropriate pre- and post-treatment medications must be given, including a corticosteroid plus blocking agents for both H1 and H2 receptors, in order to decrease the potential for severe systemic adverse reactions, including death, from mast cell degranulation. For full prescribing information, contact VIRBAC at 1-800-338-3659 or view the Product Insert or visit https://vet-us.virbac.com/stelfonta.

View the Course on dvm360 Flex